Clinical Trial Update: Study to Evaluate Ibudilast and TMZ Combo Treatment in Newly Diagnosed and Recurrent Glioblastoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial evaluating the combination of ibudilast and temozolomide in newly diagnosed and recurrent glioblastoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Temodar (Temozolomide)
• ibudilast (ibudilast)

Snippet

Sponsor: MediciNova | Conditions: Glioblastoma, Recurrent Glioblastoma | Phase 1, Phase 2 | Status: COMPLETED